Hemostasis in Newly Diagnosed Multiple Myeloma Patients before and after Induction Therapy

被引:0
|
作者
Urnova, Evdokia S. [1 ]
Mendeleeva, Larisa P. [1 ]
Pokrovskaya, Olga S. [1 ]
Gracheva, Marina A. [2 ]
Gemdzhian, Eduard G. [3 ]
Kuzmina, Larisa A. [4 ]
Tarandovsky, Ivan D. [5 ]
Firsova, Maiia V. [4 ]
Nareiko, Mariya V. [4 ]
Seregina, Elena A. [2 ]
Balandina, Anna N. [2 ]
Ataullakhanov, Fazoil I. [2 ,6 ]
Vasil'ev, Sergei A. [6 ]
Savchenko, Valeri G. [6 ]
机构
[1] Natl Res Ctr Hematol, Dept High Dose Chemotherapy, Moscow, Russia
[2] Ctr Pediat Hematol, Moscow, Russia
[3] Natl Res Ctr Hematol, Biostat, Moscow, Russia
[4] Natl Res Ctr Hematol, Dept BMT, Moscow, Russia
[5] Natl Res Ctr Hematol, Lab Phys Biochem, Moscow, Russia
[6] Natl Res Ctr Hematol, Moscow, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] RVD Induction Followed by Consolidation with ASCT in Patients with Newly Diagnosed Multiple Myeloma
    Luskin, Marlise R.
    Campigotto, Federico
    Richardson, Paul G.
    Koreth, John
    Ghobrial, Irene M.
    Schlossman, Robert
    Soiffer, Robert J.
    Munshi, Nikhil C.
    Warren, Diane
    Gannon, Muriel
    Finn, Kathleen
    Anderson, Kenneth C.
    Weller, Edie
    Laubach, Jacob P.
    BLOOD, 2011, 118 (21) : 1767 - 1768
  • [22] von Willebrand factor level in newly diagnosed patient with multiple myeloma after the first cycles of induction therapy
    Hait, E.
    Abdulkadyrov, K.
    Papayan, L.
    Golovina, O.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 58 - 58
  • [23] Thalidomide/Dexamethasone Induction Therapy in Newly Diagnosed Myeloma Patients with Renal Failure
    Tosi, P.
    Tacchetti, P.
    Zamagni, E.
    Tacchetti, P.
    Ceccolini, M.
    Perrone, G.
    Brioli, A.
    Pallotti, M. C.
    Petrucci, A.
    Baccarani, M.
    Cavo, M.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S30
  • [24] Impact of NRAS mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma
    Mishima, Yuko
    Shirouchi, Yuko
    Takayama, Tomoko
    Minowa, Sayuri
    Ishihara, Yuko
    Hirano, Kei
    Hirano, Mitsuhito
    Yoshida, Kikuaki
    Teramoto, Yukako
    Yamauchi, Nobuhiko
    Low, Siew-Kee
    Maruyama, Dai
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2025, 65 (01) : 72 - 76
  • [25] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    BLOOD, 2017, 130
  • [26] Oprozomib in patients with newly diagnosed multiple myeloma
    Hari, Parameswaran
    Matous, Jeffrey V.
    Voorhees, Peter M.
    Shain, Kenneth H.
    Obreja, Mihaela
    Frye, John
    Fujii, Hisaki
    Jakubowiak, Andrzej J.
    Rossi, Davide
    Sonneveld, Pieter
    BLOOD CANCER JOURNAL, 2019, 9 (9)
  • [27] Oprozomib in patients with newly diagnosed multiple myeloma
    Parameswaran Hari
    Jeffrey V. Matous
    Peter M. Voorhees
    Kenneth H. Shain
    Mihaela Obreja
    John Frye
    Hisaki Fujii
    Andrzej J. Jakubowiak
    Davide Rossi
    Pieter Sonneveld
    Blood Cancer Journal, 9
  • [28] Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma
    Onishi, Yasushi
    Yokoyama, Hisayuki
    Katsuoka, Yuna
    Ito, Toshihiro
    Kimura, Tomohumi
    Yamamoto, Joji
    Nakajima, Shinji
    Sasaki, Osamu
    Ara, Takahide
    Minauchi, Koichiro
    Fukuhara, Osamu
    Kobayashi, Naoki
    Noji, Hideyoshi
    Ota, Shuichi
    Harigae, Hideo
    ANNALS OF HEMATOLOGY, 2020, 99 (10) : 2351 - 2356
  • [29] Early versus delayed autologous transplantation after immunomodulatory agents-based induction therapy in patients with newly diagnosed multiple myeloma
    Kumar, Shaji K.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Buadi, Francis K.
    Hayman, Suzanne R.
    Dingli, David
    Gay, Francesca
    Sinha, Shirshendu
    Leung, Nelson
    Hogan, William
    Rajkumar, S. Vincent
    Gertz, Morie A.
    CANCER, 2012, 118 (06) : 1585 - 1592
  • [30] Low-dose lenalidomide and dexamethasone therapy after melphalan-prednisolone induction in elderly patients with newly diagnosed multiple myeloma
    Yasushi Onishi
    Hisayuki Yokoyama
    Yuna Katsuoka
    Toshihiro Ito
    Tomohumi Kimura
    Joji Yamamoto
    Shinji Nakajima
    Osamu Sasaki
    Takahide Ara
    Koichiro Minauchi
    Osamu Fukuhara
    Naoki Kobayashi
    Hideyoshi Noji
    Shuichi Ota
    Hideo Harigae
    Annals of Hematology, 2020, 99 : 2351 - 2356